Study,StudyAlt,Standardized Variable Names,Merged categories,Domain,Core area
Demeyere et al (2010)1,Demeyere et al (2010),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Demeyere et al (2010)2,Demeyere et al (2010),Blood usage,Blood usage,36. Need for further intervention,Resource use
Demeyere et al (2010)3,Demeyere et al (2010),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Demeyere et al (2010)4,Demeyere et al (2010),All cause post-operative complications,Adverse events,36. Need for further intervention,Resource use
Demeyere et al (2010)5,Demeyere et al (2010),Blood usage,Blood usage,36. Need for further intervention,Resource use
Demeyere et al (2010)6,Demeyere et al (2010),,Adverse events,38. Adverse events/effects,Adverse events
Demeyere et al (2010)7,Demeyere et al (2010),,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological 
Demeyere et al (2010)8,Demeyere et al (2010),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological/Clinical
Pieters et al. (2015)1,Pieters et al. (2015),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Pieters et al. (2015)2,Pieters et al. (2015),Blood usage,Blood usage,36. Need for further intervention,Resource use
Pieters et al. (2015)3,Pieters et al. (2015),,,36. Need for further intervention,Resource use
Pieters et al. (2015)4,Pieters et al. (2015),,,36. Need for further intervention,Resource use
Pieters et al. (2015)5,Pieters et al. (2015),,,36. Need for further intervention,Resource use
Pieters et al. (2015)6,Pieters et al. (2015),,Other,32. Delivery of care,Life impact
Pieters et al. (2015)7,Pieters et al. (2015),,Need for additional treatment,36. Need for further intervention,Resource use
Pieters et al. (2015)8,Pieters et al. (2015),,Other laboratory measures,2. Blood and lymphatic system outcomes,Physiological 
Pieters et al. (2015)9,Pieters et al. (2015),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Pieters et al. (2015)10,Pieters et al. (2015),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Pieters et al. (2015)11,Pieters et al. (2015),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Pieters et al. (2015)12,Pieters et al. (2015),Other laboratory measurements,Other laboratory measurements,"22.Respiratory, thoracic and mediastinal outcomes",Physiological
Pieters et al. (2015)13,Pieters et al. (2015),Length of stay (LOS),Length of stay,35 Hospital,Resource use
Pieters et al. (2015)14,Pieters et al. (2015),Length of stay (LOS),Length of stay,35 Hospital,Resource use
Bartelmaos et al. (2013)1,Bartelmaos et al. (2013),Blood usage,Blood usage,36. Need for further intervention,Resource use
Bartelmaos et al. (2013)2,Bartelmaos et al. (2013),Blood usage,Blood usage,36. Need for further intervention,Resource use
Bartelmaos et al. (2013)3,Bartelmaos et al. (2013),Blood usage,Blood usage,36. Need for further intervention,Resource use
Bartelmaos et al. (2013)4,Bartelmaos et al. (2013),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Bartelmaos et al. (2013)5,Bartelmaos et al. (2013),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bartelmaos et al. (2013)6,Bartelmaos et al. (2013),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bartelmaos et al. (2013)7,Bartelmaos et al. (2013),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bartelmaos et al. (2013)8,Bartelmaos et al. (2013),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Bindi et al. (2013)9,Bindi et al. (2013),Viscoelastic tests,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)10,Bindi et al. (2013),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)11,Bindi et al. (2013),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)12,Bindi et al. (2013),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)13,Bindi et al. (2013),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)14,Bindi et al. (2013),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Bindi et al. (2013)1,Bindi et al. (2013),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)2,French et al. (2003),INR,INR,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)3,French et al. (2003),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)4,French et al. (2003),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)5,French et al. (2003),,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)6,French et al. (2003),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
French et al. (2003)7,French et al. (2003),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Chong Sung et al. (2006)1,Chong Sung et al. (2006),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Chong Sung et al. (2006)2,Chong Sung et al. (2006),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Chong Sung et al. (2006)3,Chong Sung et al. (2006),,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Chong Sung et al. (2006)4,Chong Sung et al. (2006),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Chong Sung et al. (2006)5,Chong Sung et al. (2006),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Chong Sung et al. (2006)6,Chong Sung et al. (2006),Blood usage,Blood usage,36. Need for further intervention,Resource use
Chong Sung et al. (2006)7,Chong Sung et al. (2006),Blood usage,Blood usage,36. Need for further intervention,Resource use
Chong Sung et al. (2006)8,Chong Sung et al. (2006),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Chong Sung et al. (2006)9,Chong Sung et al. (2006),Mortality,Mortality,1.  Mortality/Survival,Death
Tollofsrud et al. (2003)1,Tollofsrud et al. (2003),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Tollofsrud et al. (2003)2,Tollofsrud et al. (2003),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Tollofsrud et al. (2003)3,Tollofsrud et al. (2003),,Blood usage,36. Need for further intervention,Resource use
Tollofsrud et al. (2003)4,Tollofsrud et al. (2003),,Blood usage,36. Need for further intervention,Resource use
Tollofsrud et al. (2003)5,Tollofsrud et al. (2003),,Blood usage,36. Need for further intervention,Resource use
Tollofsrud et al. (2003)6,Tollofsrud et al. (2003),Blood usage,Blood usage,36. Need for further intervention,Resource use
Tollofsrud et al. (2003)7,Tollofsrud et al. (2003),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Tollofsrud et al. (2003)8,Tollofsrud et al. (2003),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Yiu et al. (2006)1,Yiu et al. (2006),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Yiu et al. (2006)2,Yiu et al. (2006),Adverse events,Adverse events,38. Adverse events/effects,adverse events
Yiu et al. (2006)3,Yiu et al. (2006),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Yiu et al. (2006)4,Yiu et al. (2006),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Müller et al. (2015)1,Müller et al. (2015),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Müller et al. (2015)2,Müller et al. (2015),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Müller et al. (2015)3,Müller et al. (2015),Mortality,Mortality,1. Mortality/survival,Death
Müller et al. (2015)4,Müller et al. (2015),Length of stay (LOS),Length of stay,35. Hospital,Resource use
Müller et al. (2015)5,Müller et al. (2015),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Innerhofer et al. (2017)1,Innerhofer et al. (2017),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Innerhofer et al. (2017)2,Innerhofer et al. (2017),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiology
Innerhofer et al. (2017)3,Innerhofer et al. (2017),Blood usage,Blood usage,36. Need for further intervention,Resource use
Innerhofer et al. (2017)4,Innerhofer et al. (2017),Length of stay (LOS),Length of stay,35. Hospital,Resource use
Innerhofer et al. (2017)5,Innerhofer et al. (2017),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Innerhofer et al. (2017)6,Innerhofer et al. (2017),Mortality,Mortality,1. Mortality/survival,Death
Steiner et al. (2016)1,Steiner et al. (2016),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Steiner et al. (2016)2,Steiner et al. (2016),Mortality,Mortality,1.  Mortality/Survival,Death
Steiner et al. (2016)3,Steiner et al. (2016),Treatment failure,Organ specific treatment effect,24. Vascular outcomes,Clinical
Steiner et al. (2016)4,Steiner et al. (2016),Treatment failure,Organ specific treatment effect,17. Nervous system outcomes,Clinical
Steiner et al. (2016)5,Steiner et al. (2016),Treatment failure,Organ specific treatment effect,17. Nervous system outcomes,Clinical
Steiner et al. (2016)6,Steiner et al. (2016),Treatment failure,Life impact,25. Physical functioning,Life impact
Steiner et al. (2016)7,Steiner et al. (2016),Treatment failure,Organ specific treatment effect,25. Physical functioning,Life impact
Steiner et al. (2016)8,Steiner et al. (2016),Treatment failure,Life impact,30. Global quality of life,Life impact
Steiner et al. (2016)9,Steiner et al. (2016),Feasibility,Feasibility,32. Delivery of care,Life impact
Steiner et al. (2016)10,Steiner et al. (2016),Feasibility,Feasibility,32. Delivery of care,Life impact
Steiner et al. (2016)11,Steiner et al. (2016),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Goldstein et al. (2015)1,Goldstein et al. (2015),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Goldstein et al. (2015)2,Goldstein et al. (2015),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Goldstein et al. (2015)3,Goldstein et al. (2015),,Adverse events,38. Adverse events/effects,Adverse events
Goldstein et al. (2015)4,Goldstein et al. (2015),Blood usage,Blood usage,36. Need for further intervention,Resource use
Goldstein et al. (2015)5,Goldstein et al. (2015),Blood usage,Blood usage,36. Need for further intervention,Resource use
Goldstein et al. (2015)6,Goldstein et al. (2015),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Goldstein et al. (2015)7,Goldstein et al. (2015),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Sarode et al. (2013)1,Sarode et al. (2013),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Sarode et al. (2013)2,Sarode et al. (2013),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Sarode et al. (2013)3,Sarode et al. (2013),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Sarode et al. (2013)4,Sarode et al. (2013),Other laboratory measurements,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Sarode et al. (2013)5,Sarode et al. (2013),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Sarode et al. (2013)6,Sarode et al. (2013),Time specific mortality,Mortality,Mortality/Survival,Death
Lancé et al. (2012)1,Lancé et al. (2012),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Lancé et al. (2012)2,Lancé et al. (2012),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Lancé et al. (2012)3,Lancé et al. (2012),Other laboratory measurements,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Lancé et al. (2012)4,Lancé et al. (2012),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Lancé et al. (2012)5,Lancé et al. (2012),Viscoelastic tests,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Lancé et al. (2012)6,Lancé et al. (2012),Other laboratory measurements,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Etemadreziae et al. (2007)1,Etemadreziae et al. (2007),All cause post-operative complications,Organ specific treatment effect,17. Nervous system outcomes,Clinical
Etemadreziae et al. (2007)2,Etemadreziae et al. (2007),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Etemadreziae et al. (2007)3,Etemadreziae et al. (2007),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Etemadreziae et al. (2007)4,Etemadreziae et al. (2007),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Etemadreziae et al. (2007)5,Etemadreziae et al. (2007),All cause post-operative complications,Adverse events,36. Need for further intervention,Resource use
Etemadreziae et al. (2007)6,Etemadreziae et al. (2007),All cause post-operative complications,Organ specific treatment effect,17,Clinical
Etemadreziae et al. (2007)7,Etemadreziae et al. (2007),Time specific mortality,Mortality,1. Mortality/survival,Death
Sperry et al (2018)1,Sperry et al (2018),Mortality,Mortality,1. Mortality/survival,Death
Sperry et al (2018)2,Sperry et al (2018),,Blood usage,,
Sperry et al (2018)3,Sperry et al (2018),,Blood usage,,
Sperry et al (2018)4,Sperry et al (2018),Blood usage,Blood usage,36. Need for further intervention,Resource use
Sperry et al (2018)5,Sperry et al (2018),?,Need for additional treatment,36. Need for further intervention,Resource use
Sperry et al (2018)6,Sperry et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Sperry et al (2018)7,Sperry et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Sperry et al (2018)8,Sperry et al (2018),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Sperry et al (2018)9,Sperry et al (2018),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Stensballe et al (2018)1,Stensballe et al (2018),Other laboratory measurements,Other laboratory measurements,24. Vascular outcomes,Physiological
Stensballe et al (2018)2,Stensballe et al (2018),Other laboratory measurements,Other laboratory measurements,11. Immune system outcomes,Physiological
Stensballe et al (2018)3,Stensballe et al (2018),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Stensballe et al (2018)4,Stensballe et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Stensballe et al (2018)5,Stensballe et al (2018),? ,Need for additional treatment,36. Need for further intervention,Resource use
Stensballe et al (2018)6,Stensballe et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Stensballe et al (2018)7,Stensballe et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Stensballe et al (2018)8,Stensballe et al (2018),Mortality,Mortality,1. Mortality/survival,Death
Stensballe et al (2018)9,Stensballe et al (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Stensballe et al (2018)10,Stensballe et al (2018),,Length of stay,35. Hospital,Resource use
Stensballe et al (2018)11,Stensballe et al (2018),Length of stay (LOS),Length of stay,35. Hospital,Resource use
Stensballe et al (2018)12,Stensballe et al (2018),?,Other,34. Economic,Resource use
Tamura et al (2020)1,Tamura et al (2020),Viscoelastic tests,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Tamura et al (2020)2,Tamura et al (2020),,Blood usage,36. Need for further intervention,Resource use
Tamura et al (2020)3,Tamura et al (2020),,Blood usage,36. Need for further intervention,Resource use
Tamura et al (2020)4,Tamura et al (2020),Blood usage,Blood usage,36. Need for further intervention,Resource use
Tamura et al (2020)5,Tamura et al (2020),bleeding,bleeding,24. Vascular outcomes,Clinical
Tamura et al (2020)6,Tamura et al (2020),Length of stay (LOS),Length of stay,35 Hospital,Resource use
Zhang et al (20219)1,Zhang et al (20219),Mortality,Mortality,1. Mortality/survival,Death
Zhang et al (20219)2,Zhang et al (20219),All cause post-operative complications,Adverse events,38. Adverse events/effects,Adverse events
Zhang et al (20219)3,Zhang et al (20219),Length of stay (LOS),Length of stay,35 Hospital,Resource use
Zhang et al (20219)4,Zhang et al (20219),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Carson JL et al (2021)1,Carson JL et al (2021),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Carson JL et al (2021)2,Carson JL et al (2021),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Carson JL et al (2021)3,Carson JL et al (2021),Bleeding,Bleeding,2. Blood and lymphatic system outcomes,Physiological
Carson JL et al (2021)4,Carson JL et al (2021),,Blood usage,36. Need for further intervention,Resource use
Carson JL et al (2021)5,Carson JL et al (2021),,Blood usage,36. Need for further intervention,Resource use
Carson JL et al (2021)6,Carson JL et al (2021),Blood usage,Blood usage,36. Need for further intervention,Resource use
Carson JL et al (2021)7,Carson JL et al (2021),,Adverse events,38. Adverse events/effects,Adverse events
Carson JL et al (2021)8,Carson JL et al (2021),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Carson JL et al (2021)9,Carson JL et al (2021),Length of stay (LOS),Length of stay,35. Hospital,Resource use
Garrigue et al (2017)1,Garrigue et al (2017),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)2,Garrigue et al (2017),Blood usage,Feasibility,32. Delivery of care,Life impact
Garrigue et al (2017)3,Garrigue et al (2017),,Need for additional treatment,36. Need for further intervention,Resource use
Garrigue et al (2017)4,Garrigue et al (2017),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)5,Garrigue et al (2017),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)6,Garrigue et al (2017),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)7,Garrigue et al (2017),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)8,Garrigue et al (2017),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Garrigue et al (2017)9,Garrigue et al (2017),Other laboratory measurements,Other laboratory measurements,"22. Respiratory, thoracic and mediastinal outcomes",Physiological
Garrigue et al (2017)10,Garrigue et al (2017),,Need for additional treatment,36. Need for further intervention,Resource use
Garrigue et al (2017)11,Garrigue et al (2017),,Blood usage,36. Need for further intervention,Resource use
Garrigue et al (2017)12,Garrigue et al (2017),,Blood usage,36. Need for further intervention,Resource use
Garrigue et al (2017)13,Garrigue et al (2017),Blood usage,Blood usage,36. Need for further intervention,Resource use
Garrigue et al (2017)14,Garrigue et al (2017),Mortality,Mortality,35. Hospital,Resource use
Green et al (2020)1,Green et al (2020),? ,Other  ,32. Delivery of care,Life impact
Green et al (2020)2,Green et al (2020),?,Other,32. Delivery of care,Life impact
Green et al (2020)3,Green et al (2020),,Blood usage,36. Need for further intervention,Resource use
Green et al (2020)4,Green et al (2020),,Blood usage,36. Need for further intervention,Resource use
Green et al (2020)5,Green et al (2020),Blood usage,Blood usage,36. Need for further intervention,Resource use
Green et al (2020)6,Green et al (2020),? ,Need for additional treatment,36. Need for further intervention,Resource use
Green et al (2020)7,Green et al (2020),bleeding,bleeding,24. Vascular outcomes,Clinical
Green et al (2020)8,Green et al (2020),?,Organ specific treatment effect,32. Delivery of care,Life impact
Green et al (2020)9,Green et al (2020),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)10,Green et al (2020),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)11,Green et al (2020),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)12,Green et al (2020),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)13,Green et al (2020),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)14,Green et al (2020),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Green et al (2020)15,Green et al (2020),Feasibility,Feasibility,32. Delivery of care,Life impact
Green et al (2020)16,Green et al (2020),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Karkouti et al (2021)1,Karkouti et al (2021),Bleeding,Bleeding,24. Vascular outcomes,Physiological/Clinical
Karkouti et al (2021)2,Karkouti et al (2021),,Blood usage,,
Karkouti et al (2021)3,Karkouti et al (2021),,Blood usage,,
Karkouti et al (2021)4,Karkouti et al (2021),Blood usage,Blood usage,36. Need for further intervention,Resource use
Karkouti et al (2021)5,Karkouti et al (2021),bleeding,bleeding,24. Vascular outcomes,Clinical
Karkouti et al (2021)6,Karkouti et al (2021),?,Need for additional treatment,36. Need for further intervention,Resource use
Karkouti et al (2021)7,Karkouti et al (2021),bleeding,bleeding,24. Vascular outcomes,Clinical
Massoumi G et al (2018)1,Massoumi G et al (2018),Bleeding ,Bleeding,24. Vascular outcomes,Clinical
Massoumi G et al (2018)2,Massoumi G et al (2018),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Massoumi G et al (2018)3,Massoumi G et al (2018),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Massoumi G et al (2018)4,Massoumi G et al (2018),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Massoumi G et al (2018)5,Massoumi G et al (2018),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Massoumi G et al (2018)6,Massoumi G et al (2018),Bleeding,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)1,Moore et al. (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Moore et al. (2018)2,Moore et al. (2018),Viscoelastic tests,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)3,Moore et al. (2018),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)4,Moore et al. (2018),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)5,Moore et al. (2018),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)6,Moore et al. (2018),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Moore et al. (2018)7,Moore et al. (2018),,Need for additional treatment,36. Need for further intervention,Resource use
Moore et al. (2018)8,Moore et al. (2018),,Blood usage,36. Need for further intervention,Resource use
Moore et al. (2018)9,Moore et al. (2018),,Blood usage,36. Need for further intervention,Resource use
Moore et al. (2018)10,Moore et al. (2018),Blood usage,Blood usage,36. Need for further intervention,Resource use
Moore et al. (2018)11,Moore et al. (2018),?,Need for additional treatment,36. Need for further intervention,Resource use
Moore et al. (2018)12,Moore et al. (2018),?,Need for additional treatment,36. Need for further intervention,Resource use
Moore et al. (2018)13,Moore et al. (2018),?,Need for additional treatment,36. Need for further intervention,Resource use
Moore et al. (2018)1,Moore et al. (2018),?,Feasibility,32,Life impact
Moore et al. (2018)2,Moore et al. (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Moore et al. (2018)3,Moore et al. (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Moore et al. (2018)4,Moore et al. (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Moore et al. (2018)5,Moore et al. (2018),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Moore et al. (2018)6,Moore et al. (2018),Time specific mortality,Mortality,1. Mortality/survival,Death
Morrison et al (2019)7,Morrison et al (2019),Blood usage,Blood usage,36. Need for further intervention,Resource use
Morrison et al (2019)8,Morrison et al (2019),,Blood usage,36. Need for further intervention,Resource use
Morrison et al (2019)9,Morrison et al (2019),,Blood usage,36. Need for further intervention,Resource use
Morrison et al (2019)10,Morrison et al (2019),,Need for additional treatment,36. Need for further intervention,Resource use
Morrison et al (2019)11,Morrison et al (2019),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Morrison et al (2019)12,Morrison et al (2019),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological/clinical
Morrison et al (2019)13,Morrison et al (2019),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Morrison et al (2019)14,Morrison et al (2019),?,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Morrison et al (2019)15,Morrison et al (2019),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Morrison et al (2019)16,Morrison et al (2019),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Morrison et al (2019)17,Morrison et al (2019),Mortality,Mortality,1. Mortality/survival,Death
Morrison et al (2019)18,Morrison et al (2019),Length of stay (LOS),Length of stay,35. Hospital,Life impact
Morrison et al (2019)19,Morrison et al (2019),Length of stay (LOS),Length of stay,35. Hospital,Life impact
Smith et al (2022)1,Smith et al (2022),bleeding,Bleeding,24. Vascular outcomes,Clinical
Smith et al (2022)2,Smith et al (2022),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Smith et al (2022)3,Smith et al (2022),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Smith et al (2022)4,Smith et al (2022),Blood usage,Blood usage,36. Need for further intervention,Resource use
Smith et al (2022)5,Smith et al (2022),Bleeding,Bleeding,24. Vascular outcomes,Clinical
Smith et al (2022)6,Smith et al (2022),,Blood usage,36. Need for further intervention,Resource use
Smith et al (2022)7,Smith et al (2022),,Blood usage,36. Need for further intervention,Resource use
Smith et al (2022)8,Smith et al (2022),Blood usage,Blood usage,36. Need for further intervention,Resource use
Smith et al (2022)9,Smith et al (2022),,Need for additional treatment,36. Need for further intervention,Resource use
Smith et al (2022)10,Smith et al (2022),Other laboratory measurements,Other laboratory measurements ,2. Blood and lymphatic system outcomes,Physiological
Smith et al (2022)11,Smith et al (2022),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Smith et al (2022)12,Smith et al (2022),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Smith et al (2022)13,Smith et al (2022),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Smith et al (2022)14,Smith et al (2022),,Length of stay,35. Hospital,Resource use
Smith et al (2022)15,Smith et al (2022),Length of stay (LOS),Length of stay,35. Hospital,Resource use
Smith et al (2022)16,Smith et al (2022),Mortality,Mortality,1. Mortality/survival,Death
Smith et al (2022)17,Smith et al (2022),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Jost et al (2022)1,Jost et al (2022),INR,INR,2. Blood and lymphatic system outcomes,Physiological
Jost et al (2022)2,Jost et al (2022),,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Jost et al (2022)3,Jost et al (2022),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Jost et al (2022)4,Jost et al (2022),Coagulation factor concentrations,Measures of coagulation,2. Blood and lymphatic system outcomes,Physiological
Jost et al (2022)5,Jost et al (2022),Blood usage,Blood usage,36. Need for further intervention,Resource use
Jost et al (2022)6,Jost et al (2022),,Blood usage,36. Need for further intervention,Resource use
Jost et al (2022)7,Jost et al (2022),,Blood usage,36. Need for further intervention,Resource use
Jost et al (2022)8,Jost et al (2022),Blood usage,Blood usage,36. Need for further intervention,Resource use
Jost et al (2022)9,Jost et al (2022),,Adverse events,36. Need for further intervention,Resource use
Jost et al (2022)10,Jost et al (2022),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Jost et al (2022)11,Jost et al (2022),Mortality,Mortality,1. Mortality/survival,Death
Jost et al (2022)12,Jost et al (2022),Mortality,Mortality,1. Mortality/survival,Death
Jost et al (2022)13,Jost et al (2022),Adverse events,Adverse events,38. Adverse events/effects,Adverse events
Jost et al (2022)14,Jost et al (2022),,Other laboratory measurements,"22. Respiratory, thoracic and mediastinal outcomes",Physiological
Jost et al (2022)15,Jost et al (2022),Other laboratory measurements,Other laboratory measurements,2. Blood and lymphatic system outcomes,Physiological
Jost et al (2022)16,Jost et al (2022),Blood usage,Blood usage,36. Need for further intervention,Resource use
Jost et al (2022)17,Jost et al (2022),Feasibility,Feasibility,32. Delivery of care,Life impact
Jost et al (2022)18,Jost et al (2022),Feasibility,Feasibility,32. Delivery of care,Life impact
Jost et al (2022)19,Jost et al (2022),,Length of stay,35. Hospital,Resource use
Jost et al (2022)20,Jost et al (2022),Length of stay (LOS),Length of stay,35. Hospital,Resource use
